Prot#PLX 108-03: A Phase 2 Safety and Efficacy Study of Orally Administered PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date1/21/111/21/14

Funding

  • Plexxikon Inc. (PLX 108-03)